Work

Immunogenicity of Trastuzumab Intravenous and Subcutaneous Formulations in the Phase III Hannah Study

Year: 2012

Type: article

Source: Annals of Oncology

DOI: 10.1016/s0923-7534(20)32835-0

Authors: R. Hegg, T. Pienkowski, S. Chen, E. Staroslawska, S. Falcon, N. Kovalenko, N. Al-Sakaff, D. Heinzmann, G. Kolaitis, G. Ismael

Institutions: Hospital da Mulher São Paulo, The Maria Sklodowska-Curie National Research Institute of Oncology, Chang Gung Memorial Hospital, Changhua Christian Hospital, Lublin Oncology Center, Hospital Nacional Edgardo Rebagliati Martins, Stavropol Regional Clinical Oncology Center, F. Hoffmann-La Roche AG, Hospital Amaral Carvalho

Language: English

Topic: HER2/EGFR in Cancer Research

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

OpenAlex ID: W2999794381

FWCI: 0.491

Cites:

Cited by: 10

Related to: 10